Cargando…
Tim‐3 suppresses autoimmune hepatitis via the p38/MKP‐1 pathway in Th17 cells
T‐cell immunoglobulin‐ and mucin‐domain‐containing molecule‐3 (Tim‐3) mediates T‐cell suppression in various autoimmune diseases, such as chronic inflammatory liver disease. However, the regulatory effect of Tim‐3 on Th17 cells in autoimmune hepatitis (AIH) is incompletely understood. Here, we studi...
Autores principales: | Wu, Hongwei, Tang, Shiyue, Zhou, Mengya, Xue, Jiji, Yu, Zhenjun, Zhu, Jiansheng |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
John Wiley and Sons Inc.
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8091815/ https://www.ncbi.nlm.nih.gov/pubmed/33728805 http://dx.doi.org/10.1002/2211-5463.13148 |
Ejemplares similares
-
Tim-3 Relieves Experimental Autoimmune Encephalomyelitis by Suppressing MHC-II
por: Tang, Lili, et al.
Publicado: (2022) -
MKP-3 suppresses LPS-induced inflammatory responses in HUVECs via inhibition of p38 MAPK/NF-κB pathway
por: Unenkhuu, Banzragchgarav, et al.
Publicado: (2021) -
MKP-4 suppresses hepatocarcinogenesis by targeting ERK1/2 pathway
por: Shen, Zhongyi, et al.
Publicado: (2019) -
Enhanced Th17 Responses in Patients with Autoimmune Hepatitis
por: Behfarjam, Farinaz, et al.
Publicado: (2019) -
Functional analysis of MKP-1 and MKP-2 in breast cancer tamoxifen sensitivity
por: Haagenson, Kelly K., et al.
Publicado: (2014)